ADAM REYNOLDS, MD

ABOUT DR. REYNOLDS:

A Buckeye through and through, Dr. Reynolds completed his undergraduate education at the Ohio State University where he was inducted into the Phi Beta Kappa honor society and graduated with honors. He completed medical school at the Ohio State University College of Medicine, internal medicine residency at the Ohio State University Wexner Medical Center, and cardiovascular disease fellowship at the Ross Heart Hospital at the Ohio State University Wexner Medical Center. During his time in training, he was inducted into the Gold Humanism Honor Society and Landacre Research Honor Society, and received multiple awards for his research and teaching.

Dr. Reynolds lives with his wife and two children in Dallas. He enjoys family bike rides, hiking, college football, and baseball.

BOARD CERTIFICATIONS:

• Cardiovascular Disease

• Internal Medicine

HOSPITALS:

CLINIC LOCATIONS:

EDUCATION:

• Fellowship, Cardiovascular Disease: The Ohio State University Wexner Medical Center, Columbus, OH (2015-2018)

• Residency, Internal Medicine: The Ohio State University Wexner Medical Center, Columbus, OH (2013-2015)

• Internship, Internal Medicine: The Ohio State University Wexner Medical Center, Columbus, OH (2012-2013)

• Medical School, MD Degree: The Ohio State University Wexner Medical Center, Columbus, OH (2008-2012)

• Undergraduate, BS Biology (Honors, cum laude): The Ohio State University Wexner Medical Center, Columbus, OH (2003-2007)

PROFESSIONAL ASSOCIATIONS:

• American College of Cardiology

• American College of Physicians

• American Heart Association

HONORS/AWARDS:

• Gold Humanism Honor Society (2017)

• Resident Teaching Award: Second Year Resident (2014)

• Award for Excellence in Research - Resident The Ohio State Univeristy Depertment of Internal Medicine Clinician Scientist Trainee Research Day (2014)

• Landacre Research Honor Society (2011)

• American Heart Association Student Scholarship in Cardiovascular Disease and Stroke (2009)

• Samuel J. Roessler Memorial Research Scholarship (2009-2010)

PUBLICATIONS/MEDIA:

​Publications

• Covarrubias R, Chepurko E, Reynolds A, Huttinger ZM, Huttinger R, Stanfill K, Wheeler DG, Novitskaya T, Robson SC, Dwyer KM, Cowan PJ, Gumina RJ. Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice. Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1809-20. doi: 10.1161/ATVBAHA.116.307374. (2016) 

​

Quality Improvement Projects

• Coronary ischemia evaluation (CIE):  Does a clinical practice guideline improve appropriateness of tests ordered by providers?  (2016-2018)

​

• Demographic differences in cardiac allograft survival in women (2016-2018)

​

• The Association of Hospital Discharge Guideline-Directed Medical Therapy Target Dosing on Heart Failure 90-Day and 1-Year Readmission and Mortality Rates in a Single Center’s Academic and Academic-Community Hybrid Experience (2014-2015)

​

Book Chapters

• Zareba K and Reynolds A. Cardiac Magnetic Resonance in Heart Failure. In: Sawyer D and Ramachandran V, eds. Encyclopedia of Cardiovascular Research and Medicine. 1st ed. Elsevier; 2017. 

​

• Khayat R, Lilly S, and Reynolds A. Diastolic Heart Failure. In: Lilly S and Baliga R, eds. Color Atlas and Synopsis of Interventional Cardiology. 1st ed. McGraw-Hill Education; 2018. 

​

Oral Presentations

• “Coronary Artery Ectasia.” The Ohio State University Division of Cardiovascular Medicine, Columbus, OH. February 22, 2017. 

​

• “Spontaneous Coronary Artery Dissection.” The Ohio State University Division of Cardiovascular Medicine, Columbus, OH. October 31, 2016. 

​

• “Closure of Atrial Septal Defects: Current Guidelines, New Research.” Nationwide Children’s Hospital, The Heart Center, Columbus, OH. October 21, 2016. 

​

• “Peripheral Vascular Disease.” The Ohio State University Division of Cardiovascular Medicine, Columbus, OH. February 22, 2016. “Diastolic dysfunction: Are we there yet?” The Ohio State University Division of Cardiovascular Medicine Grand Rounds. Columbus, OH. January 22, 2016. 

​

• “Guideline Review: STEMI.” The Ohio State University Division of Cardiovascular Medicine, Columbus, OH. November 16, 2015. Reynolds A, Huttinger ZM, Wheeler DG, Novitskaya T, Robson SC, Dwyer KM, Cowan PJ, Gumina RJ. CD39 expression on circulating blood components prolongs the time to ferric-chloride-induced carotid artery thrombosis in mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2014. Toronto, Canada. May 1, 2014. ​

​

• “Purulent Pericarditis.” The Ohio State University Department of Internal Medicine. Columbus, OH. April 9, 2014. 

​

• Reynolds A, Wheeler DG, Gumina RJ. Antioxidant Overexpression and Doxorubicin Cardiotoxicity. The Ohio State University College of Medicine Research Day. Columbus, OH. April 8, 2010.

​

Poster Presentations

• Reynolds A, Huttinger ZM, Wheeler DG, Novitskaya T, Robson SC, Dwyer KM, Cowan PJ, Gumina RJ. CD39 expression on circulating blood components prolongs the time to ferric-chloride-induced carotid artery thrombosis in mice. The Ohio State University Department of Internal Medicine Clinician Scientist Trainee Research Day. Columbus, OH. May 29, 2014.

• Reynolds A, Wheeler DG, Gumina RJ. Antioxidant Overexpression and Doxorubicin Cardiotoxicity. The Ohio State University College of Medicine Research Day. Columbus, OH. April 8, 2010.

LEAVE A REVIEW OF DR. REYNOLDS:

Please feel free to leave a comment or review on your experience at HeartPlace with Dr. Adam Reynolds. Thank You!!!​